A popular Attention Deficit Hyperactivity Disorder (ADHD) drug has been recalled after another drug was found in the package.
Azurity Pharmaceuticals has recalled their 30 milligram dextroamphetamine sulfate tablets sold under the brand name Zenzedi.
The move came after a pharmacist in Nebraska opened a bottle to find tablets of Carbinoxamine Maleate, an antihistamine drug, mixed with an ADHD drug, the Food and Drug Administration warned.
The recalled product — part of lot number F230169A — expires in June 2025 and was recalled on January 4.
Both drugs have opposite effects.
Dextroamphetamine sulfate is a stimulant while carbinoxamine maleate, an antihistamine used to treat allergies, has a sedative effect.
“Patients who take carbinoxamine instead of Zenzedi will experience less treatment for their symptoms, which may result in functional impairment and an increased risk of accidents or injuries,” the FDA explained.
The recalled product — part of lot number F230169A — expires in June 2025 and was recalled on January 4. FDA
Those who unknowingly take carbinoxamine “may experience adverse effects that include, but are not limited to, drowsiness, drowsiness, central nervous system (CNS) depression, increased eye pressure, prostate enlargement and thyroid disorders.”
People who have been diagnosed with ADHD or narcolepsy have a “reasonable probability” that an accident or injury resulting from accidental ingestion of carbinoxamine “could lead to permanent disability or death” when participating in activities that require concentration and alertness such as driving or operating heavy machinery .
Zenzedi 30 milligram tablets will be light yellow hexagonal tablets with “30” on one side and “MIA” on the other. ADHD medication should be distributed in a white bottle with black writing and “30 mg” highlighted in yellow.
Dextroamphetamine sulfate is a stimulant while carbinoxamine maleate, an antihistamine used to treat allergies, has a sedative effect. FDA
Meanwhile, carbinoxamine maleate 4-milligram tablets are white round tablets imprinted with “GL” on one side and “211” on the other.
Patients with the recalled product are advised to stop using it and return it to the place of purchase.
This news is particularly sad as the country continues to experience shortages of common ADHD medications, such as Adderall.
Categories: Trending
Source: thtrangdai.edu.vn/en/
